See how your Medicare performance compares with others in our
Stars Navigator Dashboard
High-cost medications are often prescribed when equally effective, lower-cost alternatives are available. Specialty drugs represent only 2% of prescriptions, yet account for nearly 50% of pharmacy spend. This imbalance drives affordability challenges for both health plans and members.
Our pharmacy spend solutions combine clinical expertise with data-driven insights to reduce unnecessary spend while maintaining quality and continuity. By promoting adherence to lower-cost generics and early intervention, we help slow disease progression, improve outcomes, and make care more affordable and sustainable.
Our pharmacy spend solutions optimize medication value through evidence-based collaboration, reducing pharmacy spend, improving adherence, and sustaining quality across populations.
We reduce pharmacy costs without compromising outcomes, identifying clinically equivalent, lower-cost alternatives that sustain quality care.
Every recommendation is grounded in evidence-based protocols to ensure effectiveness, patient safety, and adherence remain uncompromised.
We target the highest-impact drugs - specialty, GLP-1s, and biosimilars - where smart substitution can yield significant savings.
We identify and deprescribe costly, non-essential therapies, optimizing treatment plans while maintaining patient stability and satisfaction.
By keeping members adherent on cost-effective, first-line medications, we prevent disease progression and escalations to costly therapies through early, consistent interventions.
When high-cost drugs are in use, we pinpoint therapeutic alternatives to lower spend without sacrificing quality or trust. With a 40% conversion rate, we drive measurable, lasting savings.
Stay ahead with the latest news, insights, and innovations from MedWatchers, delivered straight to your inbox.
